• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2010 年至 2019 年在中低收入国家开展的孕产妇和围产医学随机试验:系统范围界定审查。

Randomised trials in maternal and perinatal health in low and middle-income countries from 2010 to 2019: a systematic scoping review.

机构信息

Maternal, Child and Adolescent Health Programme, Burnet Institute, Melbourne, Victoria, Australia

University of Melbourne, Melbourne, Victoria, Australia.

出版信息

BMJ Open. 2022 Jul 7;12(7):e059473. doi: 10.1136/bmjopen-2021-059473.

DOI:10.1136/bmjopen-2021-059473
PMID:35798524
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9263904/
Abstract

OBJECTIVES

To identify and map all trials in maternal health conducted in low and middle-income countries (LMIC) over the 10-year period from 2010 to 2019, to identify geographical and thematic trends, as well as comparing to global causes of maternal death and preidentified priority areas.

DESIGN

Systematic scoping review.

PRIMARY AND SECONDARY OUTCOME MEASURES

Extracted data included location, study characteristics and whether trials corresponded to causes of mortality and identified research priority topics.

RESULTS

We searched the Cochrane Central Register of Controlled Trials database, a combined registry of trials from multiple sources. Our search identified 7269 articles, 874 of which were included for analysis. Between 2010 and 2019, maternal health trials conducted in LMICs more than doubled (50-114). Trials were conducted in 61 countries-231 trials (26.4%) were conducted in Iran. Only 225 trials (25.7%) were aligned with a cause of maternal mortality. Within these trials, pre-existing medical conditions, embolism, obstructed labour and sepsis were all under-represented when compared with number of maternal deaths globally. Large numbers of studies were conducted on priority topics such as labour and delivery, obstetric haemorrhage and antenatal care. Hypertensive disorders of pregnancy, diabetes and health systems and policy-despite being high-priority topics-had relatively few trials.

CONCLUSION

Despite trials conducted in LMICs increasing from 2010 to 2019, there were significant gaps in geographical distribution, alignment with causes of maternal mortality and known research priority topics. The research gaps identified provide guidance and insight for future research conduct in low-resource settings.

TRIAL REGISTRATION NUMBER

10.17605/OSF.IO/QUJP5.

摘要

目的

识别和绘制 2010 年至 2019 年 10 年间在中低收入国家(LMIC)进行的所有孕产妇健康试验,以确定地理和主题趋势,并与全球孕产妇死亡原因和预先确定的优先领域进行比较。

设计

系统范围审查。

主要和次要结果测量

提取的数据包括位置、研究特征以及试验是否与死亡原因相对应,并确定研究优先主题。

结果

我们搜索了 Cochrane 对照试验中央注册库,这是来自多个来源的试验综合注册库。我们的搜索确定了 7269 篇文章,其中 874 篇被纳入分析。2010 年至 2019 年,在 LMIC 进行的孕产妇健康试验增加了一倍多(50-114)。这些试验在 61 个国家进行-231 项试验(26.4%)在伊朗进行。只有 225 项试验(25.7%)与孕产妇死亡原因一致。在这些试验中,与全球孕产妇死亡人数相比,既往疾病、栓塞、产程梗阻和败血症的比例都较低。大量研究针对分娩、产科出血和产前护理等优先主题进行。妊娠高血压疾病、糖尿病和卫生系统和政策尽管是高优先级主题,但相对较少有试验。

结论

尽管 2010 年至 2019 年在 LMIC 进行的试验有所增加,但在地理分布、与孕产妇死亡原因的一致性以及已知的研究优先主题方面仍存在显著差距。确定的研究差距为未来在资源匮乏环境中进行研究提供了指导和见解。

试验注册号

10.17605/OSF.IO/QUJP5.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da7/9263904/6fa32606aeb7/bmjopen-2021-059473f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da7/9263904/1c0a80278829/bmjopen-2021-059473f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da7/9263904/2376371bdcff/bmjopen-2021-059473f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da7/9263904/6fa32606aeb7/bmjopen-2021-059473f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da7/9263904/1c0a80278829/bmjopen-2021-059473f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da7/9263904/2376371bdcff/bmjopen-2021-059473f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6da7/9263904/6fa32606aeb7/bmjopen-2021-059473f03.jpg

相似文献

1
Randomised trials in maternal and perinatal health in low and middle-income countries from 2010 to 2019: a systematic scoping review.2010 年至 2019 年在中低收入国家开展的孕产妇和围产医学随机试验:系统范围界定审查。
BMJ Open. 2022 Jul 7;12(7):e059473. doi: 10.1136/bmjopen-2021-059473.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.产前皮质类固醇用于加速有早产风险的孕妇的胎儿肺成熟。
Cochrane Database Syst Rev. 2020 Dec 25;12(12):CD004454. doi: 10.1002/14651858.CD004454.pub4.
4
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.用于加速早产风险女性胎儿肺成熟的产前皮质类固醇。
Cochrane Database Syst Rev. 2017 Mar 21;3(3):CD004454. doi: 10.1002/14651858.CD004454.pub3.
5
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
Strategies for optimising antenatal corticosteroid administration for women with anticipated preterm birth.优化预期早产妇女产前糖皮质激素给药的策略。
Cochrane Database Syst Rev. 2020 May 26;5(5):CD013633. doi: 10.1002/14651858.CD013633.
7
Alternative versus standard packages of antenatal care for low-risk pregnancy.低风险妊娠的替代方案与标准产前护理套餐
Cochrane Database Syst Rev. 2015 Jul 16;2015(7):CD000934. doi: 10.1002/14651858.CD000934.pub3.
8
Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings.在非医疗机构分娩环境中使用缩宫素预防产后出血
Cochrane Database Syst Rev. 2016 Apr 14;4(4):CD011491. doi: 10.1002/14651858.CD011491.pub2.
9
Care prior to and during subsequent pregnancies following stillbirth for improving outcomes.死胎后后续妊娠前及妊娠期间的护理以改善结局。
Cochrane Database Syst Rev. 2018 Dec 17;12(12):CD012203. doi: 10.1002/14651858.CD012203.pub2.
10
Public stewardship of private for-profit healthcare providers in low- and middle-income countries.低收入和中等收入国家对私营营利性医疗服务提供者的公共管理。
Cochrane Database Syst Rev. 2016 Aug 11;2016(8):CD009855. doi: 10.1002/14651858.CD009855.pub2.

引用本文的文献

1
Identifying and assessing the capacity and experience of trial sites in low- and middle-income countries for high-quality randomised drug trials in maternal and perinatal health.识别和评估低收入和中等收入国家试验点开展孕产妇和围产期健康领域高质量随机药物试验的能力与经验。
BMJ Glob Health. 2025 Jul 27;10(7):e018063. doi: 10.1136/bmjgh-2024-018063.
2
Maternal social determinants of health: the hidden face of perinatal mortality in Mexico.孕产妇健康的社会决定因素:墨西哥围产期死亡率的隐藏面貌。
Int J Equity Health. 2025 Apr 17;24(1):105. doi: 10.1186/s12939-025-02471-w.
3
Factors Influencing Pregnant Women's Participation in Randomised Clinical Trials in India: A Qualitative Study.

本文引用的文献

1
Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach.系统评价或范围综述?在选择系统评价或范围综述方法时,作者的指南。
BMC Med Res Methodol. 2018 Nov 19;18(1):143. doi: 10.1186/s12874-018-0611-x.
2
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.PRISMA 扩展用于范围审查 (PRISMA-ScR): 清单和解释。
Ann Intern Med. 2018 Oct 2;169(7):467-473. doi: 10.7326/M18-0850. Epub 2018 Sep 4.
3
Misconduct as the main cause for retraction. A descriptive study of retracted publications and their authors.
影响印度孕妇参与随机临床试验的因素:一项定性研究
BJOG. 2025 May;132(6):772-781. doi: 10.1111/1471-0528.18074. Epub 2025 Jan 28.
4
Characteristics of longitudinal maternal health studies in sub-Saharan Africa: A systematic mapping of literature between 2012 and 2022.撒哈拉以南非洲地区孕产妇纵向健康研究的特征:2012年至2022年文献的系统梳理
Int J Gynaecol Obstet. 2025 Apr;169(1):51-62. doi: 10.1002/ijgo.16035. Epub 2024 Nov 16.
5
Eliminating gender bias in biomedical research requires fair inclusion of pregnant women and gender diverse people.消除生物医学研究中的性别偏见需要公平纳入孕妇和性别多样化人群。
Commun Med (Lond). 2024 Oct 23;4(1):211. doi: 10.1038/s43856-024-00629-1.
6
Factors influencing the participation of pregnant and lactating women in clinical trials: A mixed-methods systematic review.影响孕妇和哺乳期妇女参与临床试验的因素:一项混合方法系统评价。
PLoS Med. 2024 May 30;21(5):e1004405. doi: 10.1371/journal.pmed.1004405. eCollection 2024 May.
7
Developmental origins of disease highlight the immediate need for expanded access to comprehensive prenatal care.疾病的发育起源强调了扩大全面产前保健的迫切需要。
Front Public Health. 2022 Nov 24;10:1021901. doi: 10.3389/fpubh.2022.1021901. eCollection 2022.
不当行为作为撤稿的主要原因。对撤稿出版物及其作者的描述性研究。
Gac Sanit. 2019 Jul-Aug;33(4):356-360. doi: 10.1016/j.gaceta.2018.01.009. Epub 2018 Jun 5.
4
Retracted Publications in the Biomedical Literature from Open Access Journals.被撤稿的生物医学文献在开放获取期刊上发表。
Sci Eng Ethics. 2019 Jun;25(3):855-868. doi: 10.1007/s11948-018-0040-6. Epub 2018 Mar 7.
5
Diversity and divergence: the dynamic burden of poor maternal health.多样性与分歧:不良孕产妇健康的动态负担。
Lancet. 2016 Oct 29;388(10056):2164-2175. doi: 10.1016/S0140-6736(16)31533-1. Epub 2016 Sep 16.
6
Mapping of research on maternal health interventions in low- and middle-income countries: a review of 2292 publications between 2000 and 2012.低收入和中等收入国家孕产妇健康干预措施的研究图谱:对2000年至2012年间2292篇出版物的综述
Global Health. 2016 Sep 6;12(1):52. doi: 10.1186/s12992-016-0189-1.
7
Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group.1990年至2015年全球、区域和国家层面的孕产妇死亡率及趋势,以及基于情景的2030年预测:联合国孕产妇死亡率估计机构间小组的系统分析
Lancet. 2016 Jan 30;387(10017):462-74. doi: 10.1016/S0140-6736(15)00838-7. Epub 2015 Nov 13.
8
Global causes of maternal death: a WHO systematic analysis.全球孕产妇死亡原因:世卫组织系统分析。
Lancet Glob Health. 2014 Jun;2(6):e323-33. doi: 10.1016/S2214-109X(14)70227-X. Epub 2014 May 5.
9
Maternal and perinatal health research priorities beyond 2015: an international survey and prioritization exercise.2015年后的孕产妇和围产期健康研究重点:一项国际调查与优先排序活动
Reprod Health. 2014 Aug 7;11:61. doi: 10.1186/1742-4755-11-61.
10
A survey study identified global research priorities for decreasing maternal mortality.一项调查研究确定了降低孕产妇死亡率的全球研究重点。
J Clin Epidemiol. 2014 Mar;67(3):314-24. doi: 10.1016/j.jclinepi.2013.10.007. Epub 2014 Jan 8.